Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Olson

Showing results (61-70 of 160) with videos related to

Pageof 16
Sort By:
Oncogene|May 3, 2018
A modified gene trap approach for improved high-throughput cancer drug discoveryShelli M Morris, Andrew J Mhyre, Savanna S Carmack, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
CYpHER: Catalytic extracellular targeted protein degradation with high potency and durable effectZachary R Crook, Gregory P Sevilla, Pamela Young, et al.
Plos Genetics|April 24, 2007
Conservation of regional gene expression in mouse and human brainAndrew D Strand, Aaron K Aragaki, Zachary C Baquet, et al.
Angewandte Chemie (International Ed. in English)|March 8, 2011
Design of highly emissive polymer dot bioconjugates for in vivo tumor targetingChangfeng Wu, Stacey J Hansen, Qiong Hou, et al.
Molecular and Cellular Biology|August 8, 2012
A distinct Smoothened mutation causes severe cerebellar developmental defects and medulloblastoma in a novel transgenic mouse modelJoyoti Dey, Sally Ditzler, Sue E Knoblaugh, et al.
Nature Communications|October 9, 2024
CYpHER: catalytic extracellular targeted protein degradation with high potency and durable effectZachary R Crook, Gregory P Sevilla, Pamela Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2017
Inhibition of CDK4/6 by Palbociclib Significantly Extends Survival in Medulloblastoma Patient-Derived Xenograft Mouse ModelsMichelle L Cook Sangar, Laura A Genovesi, Madison W Nakamoto, et al.
Plos One|March 9, 2010
Rapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: a novel non-radioactive methodMichelle Jeung-Eun Lee, Omid Veiseh, Narayan Bhattarai, et al.
Oncotarget|June 10, 2017
ZNF131 suppresses centrosome fragmentation in glioblastoma stem-like cells through regulation of HAUS5Yu Ding, Jacob A Herman, Chad M Toledo, et al.
Neuro-Oncology|September 15, 2023
Preclinical pediatric brain tumor models for immunotherapy: Hurdles and a way forwardDeepak Kumar Mishra, Dean Popovski, Shelli M Morris, et al.
Pageof 16

Showing results (61-70 of 160) with videos related to

Sort By:
Pageof 16
Oncogene|May 3, 2018
A modified gene trap approach for improved high-throughput cancer drug discoveryShelli M Morris, Andrew J Mhyre, Savanna S Carmack, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
CYpHER: Catalytic extracellular targeted protein degradation with high potency and durable effectZachary R Crook, Gregory P Sevilla, Pamela Young, et al.
Plos Genetics|April 24, 2007
Conservation of regional gene expression in mouse and human brainAndrew D Strand, Aaron K Aragaki, Zachary C Baquet, et al.
Angewandte Chemie (International Ed. in English)|March 8, 2011
Design of highly emissive polymer dot bioconjugates for in vivo tumor targetingChangfeng Wu, Stacey J Hansen, Qiong Hou, et al.
Molecular and Cellular Biology|August 8, 2012
A distinct Smoothened mutation causes severe cerebellar developmental defects and medulloblastoma in a novel transgenic mouse modelJoyoti Dey, Sally Ditzler, Sue E Knoblaugh, et al.
Nature Communications|October 9, 2024
CYpHER: catalytic extracellular targeted protein degradation with high potency and durable effectZachary R Crook, Gregory P Sevilla, Pamela Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2017
Inhibition of CDK4/6 by Palbociclib Significantly Extends Survival in Medulloblastoma Patient-Derived Xenograft Mouse ModelsMichelle L Cook Sangar, Laura A Genovesi, Madison W Nakamoto, et al.
Plos One|March 9, 2010
Rapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: a novel non-radioactive methodMichelle Jeung-Eun Lee, Omid Veiseh, Narayan Bhattarai, et al.
Oncotarget|June 10, 2017
ZNF131 suppresses centrosome fragmentation in glioblastoma stem-like cells through regulation of HAUS5Yu Ding, Jacob A Herman, Chad M Toledo, et al.
Neuro-Oncology|September 15, 2023
Preclinical pediatric brain tumor models for immunotherapy: Hurdles and a way forwardDeepak Kumar Mishra, Dean Popovski, Shelli M Morris, et al.
Pageof 16